Bata India Q3 profit rises 13% on premium brand demand, margin expansion
Shares of Bata India Ltd ended at ₹882.50, up by ₹34.35, or 4.05%, on the BSE.
Uncategorized
Stocks to watch on Feb 10: Aurobindo Pharma, Marico, Railtel, Sansera Engineering, GSFC, Ramco Cements and more
From BSE Ltd’s strong net profit to Sansera Engineering’s 23.6% rise in net profit and Ramco Cements’ ₹385.6 crore net profit, these are some of the stocks to watch ahead of Tuesday’s trading session.
NCLT clears Ambuja-Sanghi merger, paving way for smoother expansion and bigger cement play
Ambuja Cements, which is already the promoter of Sanghi Industries with a 58.08% equity stake, had completed the acquisition of Sanghi at an enterprise value of about ₹5,185 crore.
Navin Fluorine Q3 Results: Profit more than doubles, margin expands sharply
Navin Fluorine delivered a strong Q3, with profit more than doubling and margins expanding sharply on robust revenue growth, even as it recognised a one-time labour code-related charge
Neuland Labs profit drops sharply in Q3 as sales slow and costs bite
The drug firm reported ₹439.7 crore in revenue, down 10.5% on a year-on-year basis and 14.8% on sequential basis. Revenue in the same quarter last year stood at ₹398 crore while previous quarter reported ₹516 crore.
GRSE and Hindustan Shipyard sign MoU to form consortium for national shipbuilding programme
Shares of Garden Reach Shipbuilders & Enginers Ltd ended at ₹2,514.35, up by ₹112.80, or 4.70%, on the BSE.
NSE cautions STT hike on equity futures could harm long-term investors, urges review
NSE warned that higher STT on equity futures could hurt long-term investors and liquidity, saying it has asked the government to review the trading tax hike.
Eicher Motors Q3 Preview: Strong Royal Enfield, commercial vehicle volumes to drive earnings
Shares of Eicher Motors Ltd ended at ₹7,209.55, up by ₹33.30, or 0.46%, on the BSE.
PNC Infratech Q3 sees profit and revenue slip as margins tighten, stock gains on project wins
Company’s revenue for the quarter fell 18.3% to ₹1,200 crore from ₹1,470 crore, while EBITDA dropped 37% to ₹238.7 crore
GlaxoSmithKline Q3 net profit surges 29% on higher revenue and EBITDA
Shares of GlaxoSmithKline Pharmaceuticals Ltd, today (Feb 9) closed at ₹2,515 on the NSE, up ₹31 or 1.25%, on NSE.